Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-02

FDA Approved: ACITRETIN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved a supplemental application for ACITRETIN from Amneal Pharmaceuticals of New York LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acitretin (Acitretin)

Snippet

SUPPL AP for ACITRETIN (ACITRETIN)